Choroidal thickness in patients with thyroid-associated ophthalmopathy, as determined by swept-source optical coherence tomography.

IF 3.7 2区 医学 Q1 OPHTHALMOLOGY British Journal of Ophthalmology Pub Date : 2024-07-23 DOI:10.1136/bjo-2023-323694
Sisi Zhong, Fanglin He, Sijie Fang, Jing Sun, Yinwei Li, Zhang Shuo, Xingtong Liu, Xuefei Song, Yang Wang, Yazhuo Huang, Huifang Zhou, Xianqun Fan
{"title":"Choroidal thickness in patients with thyroid-associated ophthalmopathy, as determined by swept-source optical coherence tomography.","authors":"Sisi Zhong, Fanglin He, Sijie Fang, Jing Sun, Yinwei Li, Zhang Shuo, Xingtong Liu, Xuefei Song, Yang Wang, Yazhuo Huang, Huifang Zhou, Xianqun Fan","doi":"10.1136/bjo-2023-323694","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study used swept-source optical coherence tomography (SS-OCT) to investigate subfoveal choroidal thickness (SFCT) in patients with thyroid-associated ophthalmopathy (TAO) who displayed different levels of disease activity and severity.</p><p><strong>Methods: </strong>Thirty patients with TAO (60 eyes) and 38 healthy controls (67 eyes) in Shanghai, China, were recruited for this study. Disease activity and severity were graded using European Group on Graves' Orbitopathy standardised criteria. SFCT values were determined by SS-OCT.</p><p><strong>Results: </strong>In total, 129 eyes were included in the final analysis. The mean SFCT was significantly thicker among patients with active disease (276.23±84.01 µm) than among patients with inactive disease (224.68±111.61 µm; p=0.049) or healthy controls (223.56±78.69 µm; p=0.01). There were no differences in SFCT among patients with moderate-to-severe disease, patients with severe disease and healthy controls (p>0.05). Changes in SFCT demonstrated strong predictive ability to distinguish active TAO from inactive TAO (area under the curve=0.659, 95% CI 0.496 to 0.822).</p><p><strong>Conclusions: </strong>SFCT was strongly associated with Clinical Activity Score in patients with TAO. Choroidal thickening was observed during active TAO. SS-OCT offers a non-invasive method for follow-up assessment.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287629/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bjo-2023-323694","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study used swept-source optical coherence tomography (SS-OCT) to investigate subfoveal choroidal thickness (SFCT) in patients with thyroid-associated ophthalmopathy (TAO) who displayed different levels of disease activity and severity.

Methods: Thirty patients with TAO (60 eyes) and 38 healthy controls (67 eyes) in Shanghai, China, were recruited for this study. Disease activity and severity were graded using European Group on Graves' Orbitopathy standardised criteria. SFCT values were determined by SS-OCT.

Results: In total, 129 eyes were included in the final analysis. The mean SFCT was significantly thicker among patients with active disease (276.23±84.01 µm) than among patients with inactive disease (224.68±111.61 µm; p=0.049) or healthy controls (223.56±78.69 µm; p=0.01). There were no differences in SFCT among patients with moderate-to-severe disease, patients with severe disease and healthy controls (p>0.05). Changes in SFCT demonstrated strong predictive ability to distinguish active TAO from inactive TAO (area under the curve=0.659, 95% CI 0.496 to 0.822).

Conclusions: SFCT was strongly associated with Clinical Activity Score in patients with TAO. Choroidal thickening was observed during active TAO. SS-OCT offers a non-invasive method for follow-up assessment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
扫源光学相干断层扫描测定甲状腺相关眼病患者的脉络膜厚度。
目的:本研究使用扫描源光学相干断层扫描(SS-OCT)研究甲状腺相关眼病(TAO)患者的脉络膜下厚度(SFCT),这些患者表现出不同程度的疾病活动性和严重程度。方法:上海地区30例TAO患者(60眼)和38例健康对照者(67眼)参加本研究。疾病活动性和严重程度采用欧洲Graves眼眶病标准化标准进行分级。结果:共有129只眼睛被纳入最终分析。活动性疾病患者的平均SFCT明显较厚(276.23±84.01 µm)高于无活动性疾病患者(224.68±111.61 µm;p=0.049)或健康对照组(223.56±78.69 µm;p=0.01)。中重度疾病患者、重度疾病患者和健康对照组的SFCT没有差异(p>0.05)。SFCT的变化显示出很强的区分活动性TAO和非活动性TAO的预测能力(曲线下面积=0.659,95%CI 0.496至0.822)。结论:SFCT与TAO患者的临床活动评分密切相关。在主动TAO期间观察到脉络膜增厚。SS-OCT为后续评估提供了一种非侵入性方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.30
自引率
2.40%
发文量
213
审稿时长
3-6 weeks
期刊介绍: The British Journal of Ophthalmology (BJO) is an international peer-reviewed journal for ophthalmologists and visual science specialists. BJO publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context.
期刊最新文献
Impact of microorganism virulence on endophthalmitis outcomes Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2 Effect of intravenous methylprednisolone on serum antibody levels in thyroid eye disease The aqueous humour dynamics in primary angle closure disease: a computational study Retinal curvature in Chinese children with myopia measured by ultra-widefield swept-source optical coherence tomography.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1